Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 55.31%-588.19K | -6.17%-466.75K | -118.48%-669.8K | 29.09%-1.96M | 172.36%105.56K | 50.87%-1.32M | 71.94%-439.62K | -118.79%-306.57K | 79.24%-2.76M | 77.83%-145.88K |
| Net income from continuing operations | 28.40%-672.54K | 5.33%-670.33K | 10.07%-604.55K | 39.36%-2.95M | 34.66%-634.86K | 60.62%-939.37K | 82.56%-708.05K | -126.43%-672.25K | 70.97%-4.87M | 17.69%-971.69K |
| Operating gains losses | -47.63%5.08K | 291.18%24.63K | 893.60%17.36K | -2,639.67%-59.02K | -1,499.71%-72.83K | 414.94%9.7K | 595.28%6.3K | -248.67%-2.19K | -92.80%2.32K | -86.57%5.2K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | -88.37%41.79K | -13.47%73.07K | -14.42%73.59K | -33.06%579.48K | 418.21%49.69K | 290.00%359.37K | -88.29%84.44K | 26.39%85.99K | -70.86%865.66K | -115.94%-15.61K |
| Other non cashItems | --8.39K | --8.11K | 839,000.00%8.39K | -79.48%13.8K | ---- | ---- | ---- | ---1 | 18.19%67.25K | --1 |
| Change In working capital | 103.90%29.09K | -44.98%97.77K | -158.39%-164.58K | -60.63%463.51K | -10.34%749.77K | -94.96%-745.82K | -89.58%177.69K | 128.73%281.87K | 182.48%1.18M | 116.72%836.22K |
| -Change in receivables | 31.90%7.16K | 122.82%670 | -43.80%-5.86K | -31.60%3.88K | -44.17%5.46K | 113.02%5.43K | -104.53%-2.94K | 85.03%-4.08K | -82.19%5.67K | -41.25%9.78K |
| -Change in prepaid assets | -936.60%-129.88K | 49.10%79.93K | -1,002.78%-97.27K | 281.26%84.79K | -84.05%24.48K | 137.84%15.53K | -28.83%53.61K | 96.24%-8.82K | -130.44%-46.78K | 168.12%153.45K |
| -Change in payables and accrued expense | 119.80%151.81K | -86.48%17.17K | -120.85%-61.46K | -69.24%374.84K | 6.96%719.82K | -155.74%-766.78K | -91.88%127.02K | 140.97%294.77K | 426.88%1.22M | 115.73%672.99K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 55.31%-588.19K | -6.17%-466.75K | -118.48%-669.8K | 29.09%-1.96M | 172.36%105.56K | 50.87%-1.32M | 71.94%-439.62K | -118.79%-306.57K | 79.24%-2.76M | 77.83%-145.88K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 33.50%1.48M | -100.00%-20 | 0 | 18.60%3.24M | 112,009,700.00%1.12M | -59.56%1.1M | 625.01K | 390.03K | -57.74%2.73M | -100.00%-1 |
| Net issuance payments of debt | 179.41%475K | -100.00%-20 | --0 | --1.3M | --1.11M | --170K | --625.01K | --390.03K | --0 | --0 |
| Net common stock issuance | 6.97%1M | ---- | ---- | -27.21%2M | 6,513,200.00%65.13K | -65.98%934.87K | --0 | ---- | -45.05%2.75M | ---1 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | -280.73%-60K | ---- | ---- | ---- | ---- | 95.15%-15.76K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 33.50%1.48M | -100.00%-20 | --0 | 18.60%3.24M | 112,009,700.00%1.12M | -59.56%1.1M | --625.01K | --390.03K | -57.74%2.73M | -100.00%-1 |
| Net cash flow | ||||||||||
| Beginning cash position | -76.16%67.59K | 435.33%558.74K | 6,725.20%1.28M | -60.00%18.78K | -63.33%62.51K | 146.38%283.47K | -93.77%104.37K | -60.00%18.78K | -99.32%46.95K | -33.96%170.46K |
| Current changes in cash | 519.78%886.81K | -351.78%-466.77K | -945.74%-705.81K | 4,763.11%1.28M | 940.17%1.23M | -496.30%-211.26K | 111.83%185.39K | -94.89%83.45K | 99.60%-27.52K | 29.84%-145.88K |
| Effect of exchange rate changes | 48.16%-5.03K | -287.28%-24.38K | -905.33%-17.23K | -2,995.87%-20.25K | -10.36%-6.39K | -562.20%-9.7K | -210.93%-6.3K | 181.24%2.14K | -109.22%-654 | -79.33%-5.79K |
| End cash Position | 1,418.66%949.37K | -76.16%67.59K | 435.33%558.74K | 6,725.20%1.28M | 6,725.20%1.28M | -63.33%62.51K | 146.38%283.47K | -93.77%104.37K | -60.00%18.78K | -60.00%18.78K |
| Free cash from | 55.31%-588.19K | -6.17%-466.75K | -118.48%-669.8K | 29.09%-1.96M | 172.36%105.56K | 50.87%-1.32M | 71.94%-439.62K | -118.79%-306.57K | 79.24%-2.76M | 77.83%-145.88K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.